Press releases

Advanced Search
  • Mar 20, 2015
    BD obtains CE Mark for the BD MAX™ CT/GC/TV and CT/GC assays, part of the BD Reproductive and Sexually Transmitted Infections portfolio

    BALTIMORE, MD, March 20, 2015 – BD Life Sciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it obtained CE...

  • Mar 17, 2015

    Becton, Dickinson and Company (NYSE: BDX) ("BD") today announced that it completed its acquisition of CareFusion Corporation ("CareFusion") pursuant to the terms of its previously announced...

  • Mar 13, 2015
    Clearance Completes Required Regulatory Approvals

    Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") announced today that the companies have received clearance from the European Commission under...

  • Mar 2, 2015
    Joint development of BD Intelliport™ Medication Management System is the first step in the creation of new injection safety market

    FRANKLIN LAKES, N.J., March 02, 2015 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the acquisition of CRISI Medical Systems, a...

  • Feb 26, 2015
    Marks Fifth Year Finishing in Top Spot for Infection Control and Monitoring Category

    February 26, 2015 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced that MedMined® Surveillance Advisor has once again finished first in a KLAS report for...